What Is the Difference Between Depression and Bipolar?

Depression and bipolar disorder share a defining feature: long stretches of low mood, fatigue, and difficulty functioning. The core difference is that bipolar disorder also includes episodes of abnormally elevated or irritable mood, called mania or hypomania, while depression (formally major depressive disorder, or MDD) does not. That single distinction sounds simple, but it creates a diagnostic puzzle that trips up clinicians for years at a time, because bipolar disorder usually shows up as depression first, and the manic side may not appear until much later.

Why the Two Conditions Look So Similar at First

A person in the depressive phase of bipolar disorder and a person with MDD can look nearly identical in a clinical interview. Both may report sadness, loss of interest, sleep problems, trouble concentrating, and thoughts of suicide. A review comparing unipolar and bipolar depression across course, symptoms, neurobiology, and psychosocial functioning found that the evidence raises a genuine question about whether the depressive episodes in each condition should even be considered the same disorder or different ones.¹ The depressive episodes overlap so much that diagnostic systems require the presence of a manic or hypomanic episode to make a bipolar diagnosis. Without that history, the default diagnosis is MDD.²

There are some subtle clues that a depressive episode might actually be bipolar depression. Bipolar depressive episodes tend to score higher on scales that measure mixed symptoms, meaning features of agitation, irritability, or racing thoughts occurring alongside the low mood. One study found that scores on a “mixed” subscale could predict bipolar depression with about 82% specificity, though the sensitivity was lower.³ People with mixed features across mood disorders tend to have more substance abuse, more suicide attempts, and a less favorable overall course.⁴

Mania and Hypomania Are What Set Bipolar Apart

Bipolar disorder comes in two main types. Bipolar I involves full manic episodes, which are periods of extremely elevated energy, reduced need for sleep, grandiosity, rapid speech, and impulsive behavior severe enough to cause real damage or require hospitalization. Bipolar II involves hypomania, a less extreme version that does not cause psychosis or necessarily wreck your life but is still a clear departure from your normal baseline. A large analysis of the two types found that bipolar II is characterized by more prominent and longer-lasting depressions with some hypomania and mixed features, but not full mania and rarely psychosis.⁵

The severity difference between bipolar I and II manic symptoms exists but is not as clear-cut as textbooks sometimes imply. One study found that bipolar I patients scored higher on manic symptom severity than bipolar II patients, but the differentiation was limited.⁶ In practice, the line between a “good day” and hypomania can be hard to draw, which is one reason bipolar II often goes unrecognized.

MDD, by contrast, has no manic or hypomanic episodes at all. The mood moves in one direction only: down. Episodes of depression may recur, sometimes frequently, but they do not alternate with periods of abnormally high energy. If a person with an MDD diagnosis later experiences a clear manic or hypomanic episode, the diagnosis gets changed to bipolar disorder.

Misdiagnosis Is Extremely Common

Bipolar disorder is one of the most frequently misdiagnosed conditions in psychiatry, especially when a person first seeks help during a depressive episode. This happens because the diagnostic criteria require a documented manic or hypomanic episode, and many people either have not had one yet, did not recognize it as abnormal, or simply did not report it.⁷ Hypomania is particularly easy to miss. A period of high productivity, decreased sleep, and elevated confidence can feel good, not like a symptom. Many people do not bring it up in a clinical visit.

The consequences of misdiagnosis are not just academic. Patients with bipolar I disorder who were initially misdiagnosed had roughly double the rate of mental-health-related hospitalizations and nearly 80% more emergency room visits compared to those who were correctly diagnosed from the start. Their healthcare costs were substantially higher as well.⁸ Misdiagnosis does not just delay the right treatment; it often leads to the wrong treatment, which can make things actively worse.

Why Getting the Diagnosis Right Changes Treatment

This is the most practical reason the distinction matters. Standard antidepressants, the go-to treatment for MDD, can destabilize people with bipolar disorder. Treating bipolar depression with antidepressants alone is generally not effective and may trigger hypomania, mania, or rapid cycling between mood states.² Clinical guidance is clear that once bipolar disorder is confirmed, traditional antidepressants should be avoided during depressive phases in favor of mood stabilizers and certain atypical antipsychotics.⁹

A systematic review of randomized trials examined the risk of switching into mania during antidepressant treatment for bipolar depression. Compared to placebo, several antidepressants showed elevated switch risks, with venlafaxine, imipramine, and desipramine among the highest, though no single antidepressant was significantly worse than another in direct comparisons.¹⁰ In people diagnosed with depression (not bipolar), prior SSRI treatment and venlafaxine use were also associated with a higher incidence of new mania or bipolar disorder diagnoses.¹¹ Whether that reflects the medication unmasking an underlying bipolar tendency or playing a causal role is debated, but clinicians watch for it.

The concern extends to younger patients. A large study of children and adolescents with unipolar depression found that antidepressant treatment was associated with a small but real increased risk of manic or hypomanic episodes over a year of follow-up.¹² The absolute risk was low, under 1% at one year, but the finding reinforces why clinicians need to think carefully about whether a young person’s depression might eventually prove to be bipolar.

Predictors That Depression Will Turn Into a Bipolar Diagnosis

A significant number of people who initially receive an MDD diagnosis are eventually reclassified as having bipolar disorder. Identifying who is at higher risk of that transition is an active area of research. A large retrospective study identified several predictors of one-year diagnostic transition from MDD to bipolar disorder: younger age at onset (especially teens and young adults), severe depression at the initial visit, the presence of psychotic features, co-occurring substance misuse, and self-harm thoughts or actions.¹³

Another analysis found a similar pattern: lower educational level, use of illicit substances, a younger age at the first depressive episode, and a family history of bipolar disorder all predicted conversion from MDD to bipolar.¹⁴ If you have been diagnosed with depression and several of these factors apply to you, it is worth discussing with your clinician, not because you definitely have bipolar disorder, but because the possibility should stay on the radar.

Shared Genetics, Different Diseases

Bipolar disorder and MDD are genetically related but distinct. They share risk alleles, meaning some of the same genetic variants contribute to both conditions. One study estimated the genetic correlation between bipolar disorder and MDD at roughly 0.45, meaning there is meaningful overlap but far from complete.¹⁵ For context, bipolar disorder’s genetic correlation with schizophrenia is even higher, around 0.7, suggesting bipolar sits at a genetic crossroads between depression and psychotic disorders.

A genome-wide analysis confirmed that MDD and bipolar disorder are genetically distinct, but the findings support the idea that healthy people, people with MDD, and people with bipolar disorder lie along a continuum of genetic risk rather than falling into completely separate categories.¹⁶ This helps explain why the two conditions share so many surface-level features and why one can evolve into the other.

Differences in the Brain

Researchers have found structural and functional brain differences between the two disorders, though none are reliable enough to serve as a diagnostic test in individual patients. A pilot study using brain imaging found that bipolar patients had larger cortical surface area in several brain regions compared to MDD patients, and a machine-learning classifier could distinguish the two groups with about 74% overall accuracy.¹⁷ Another study found that bipolar patients had thinner cortex in certain areas compared to both MDD patients and healthy volunteers, with the difference more pronounced in bipolar I.¹⁸

On the functional side, connectivity patterns in the posterior cingulate cortex, a brain region involved in self-referential thinking, differ between bipolar II and unipolar depression. That connectivity was also linked to suicidal ideation and depression severity in MDD but not in bipolar II, suggesting the two conditions may generate similar feelings through different neural routes.¹⁹

Cognitive Effects Over Time

Both conditions impair thinking, but the pattern differs. People with bipolar disorder generally appear to have a greater degree of cognitive impairment than those with MDD, though direct head-to-head comparisons within single studies have been scarce.²⁰ One study that did compare the groups in older adults found that people with MDD performed significantly better than those with bipolar disorder on verbal fluency, attention, and information processing speed. Strikingly, bipolar patients showed a similar degree of cognitive impairment to patients with schizophrenia.²¹ This is a finding that surprises many people, since bipolar disorder is not commonly associated with the cognitive difficulties seen in schizophrenia, but in later life the overlap is substantial.

Long-Term Course and Disability

One of the more sobering findings in this area is how much time people with either condition spend unwell. An analysis pooling data from over 6,400 patients treated clinically for an average of about nine years found that the proportion of time spent ill was strikingly similar across diagnoses: around 46% for MDD, 44% for bipolar I, and 43% for bipolar II. The morbidity in all three groups was predominantly depressive, with depression accounting for all of the illness time in MDD, about 81% in bipolar II, and about 70% in bipolar I.²²

Where the disorders diverge more clearly is in functional disability. People with all three diagnoses experienced some degree of disability during most of their follow-up, but bipolar I patients were completely unable to carry out work functions about 30% of assessed months, significantly more than MDD or bipolar II patients, who were at about 20-21%.²³ The manic and mixed episodes unique to bipolar I seem to extract an additional toll on work functioning that pure depression does not.

Suicide Risk Across the Conditions

Both depression and bipolar disorder carry elevated suicide risk, and the comparison between bipolar subtypes is less clear than many people assume. A meta-analysis looking specifically at completed suicide in bipolar I versus bipolar II found that the pooled odds were essentially equal, with no significant difference between the two types.²⁴ People with mixed features, whether in bipolar or MDD, tend to have more suicide attempts and higher suicidal ratings than those without mixed features.⁴ The takeaway is that suicide risk needs to be monitored closely regardless of which mood disorder diagnosis applies.

Physical Health and Metabolic Risk

Both conditions affect the body, not just the mind. People with bipolar disorder and MDD have higher rates of metabolic syndrome, a cluster of conditions including abdominal obesity, high blood sugar, high cholesterol, and high blood pressure, compared to the general population. One study found metabolic syndrome in about 47% of bipolar patients and 35% of MDD patients during a depressive episode, versus about 22% in the general population.²⁵ A separate study confirmed a higher metabolic syndrome prevalence in bipolar disorder compared to both MDD and non-psychiatric controls, even after adjusting for lifestyle factors.²⁶ Medications used to treat bipolar disorder, particularly some atypical antipsychotics, likely contribute to this gap, but the relationship between mood disorders and metabolic health is complex and goes beyond drug side effects.

The Burden on Families and Caregivers

Caring for someone with a mood disorder takes a toll on the people around them, and that burden differs between the conditions. The objective burden on caregivers of people with bipolar disorder is significantly higher than for those caring for someone with unipolar depression.²⁷ A study of caregivers of young adults with mood disorders found the same pattern, with bipolar caregivers reporting greater burden, and noted that caregiver burden was associated with the caregiver’s own risk for mood and anxiety disorders and suicidal thinking.²⁸ The unpredictability of manic episodes, which can involve impulsive spending, risky behavior, and disrupted sleep for the entire household, adds a dimension of stress that depression alone does not.

Circadian Rhythms and Body Clocks

Sleep disruption is a hallmark of both conditions, but the nature of the disruption differs. A review of the literature found that circadian rhythm dysfunction is more prominent in bipolar disorder than in MDD, to the degree that it may serve as a trait marker, meaning it is present even outside of active mood episodes.²⁹ People with depression tend to sleep too much or have difficulty falling asleep, but their underlying body clock is usually less fundamentally disrupted. In bipolar disorder, the body’s internal timing system appears to be structurally different, which may help explain why sleep loss can trigger manic episodes and why keeping a strict sleep schedule is one of the most commonly recommended lifestyle strategies for bipolar management.

Digital Tools and Early Detection

Smartphones and wearable devices are opening new ways to distinguish the two conditions, though this research is still early. A systematic review found that activity levels tracked by smartphones or wearables could potentially differentiate unipolar depression from bipolar disorder. People with bipolar disorder generally showed lower overall activity levels than those with MDD. They also tended to be more active in the morning and less active in the evening, while people with MDD showed the opposite pattern.³⁰

An exploratory study using machine learning on smartphone data, including call patterns and self-reported mood, found that patients with bipolar disorder during both euthymic and depressive states had fewer incoming phone calls per day than those with unipolar depression. Classifiers built on this data looked promising in initial testing but performed poorly when asked to generalize to new, unseen patients.³¹ The technology is not ready for clinical use, but it points toward a future where passive data collection could help flag people at risk of having their depression reclassified.